-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Keyuan Pharmaceutical holds a special meeting on new product introduction and existing product improvement, accelerating its product strategy deployment!
Publish Time:
2025-02-05
To further enhance the company’s core competitiveness and fully meet and adapt to market demands, Keyuan Pharmaceutical successfully organized a special meeting on new product introduction and another on improving and upgrading existing products on February 4. The meetings centered around the "One Core, Two Wings, Three Pillars" development strategy, delving into discussions on new product planning and strategies for enhancing current offerings, thereby driving the company toward transformation, upgrading, and high-quality growth.
To further enhance the company’s core competitiveness and fully meet and adapt to market demands, Keyuan Pharmaceutical successfully organized a special meeting on new product introduction and another on improving and upgrading existing products on February 4. The meetings centered around the "One Core, Two Wings, Three Pillars" development strategy, delving into discussions on new product planning and strategies for enhancing current offerings, thereby driving the company toward transformation, upgrading, and high-quality growth.
This meeting focused on core product areas such as blood sugar-lowering agents, cardiovascular drugs, and anesthetics, and featured a comprehensive exploration and discussion centered on the development plans for innovative products—including specialty raw materials, excipients, and intermediates. Attendees engaged in in-depth exchanges on the R&D directions of these new products, their market potential, and the technical challenges they may face, further clarifying the company’s key competitive advantages and outlining its future growth trajectory.
Keyuan Pharmaceutical will fully leverage its own strengths, strengthening strategic collaborations with universities, research institutions, and leading domestic R&D organizations. From the early stages of research and development all the way through to final commercial operations, the company will comprehensively adopt and advance the concepts and technologies of digital and intelligent manufacturing, fostering the emergence of new, high-quality productivity. At the same time, the company will enhance production efficiency and product quality by introducing cutting-edge technologies and equipment, while continuously reinforcing team and organizational development—building a professional, highly skilled pharmaceutical team that ensures robust talent support for the company’s sustained growth.
To further advance its new-product strategic layout, Keyuan Pharmaceutical will increase its investment efforts. Building on the stable growth of its existing product portfolio, the company will focus on accelerating the research and development of innovative products as well as enhancing their market promotion. Keyuan Pharmaceutical aims to establish itself as a globally recognized pharmaceutical enterprise, firmly demonstrating the company’s sense of responsibility, mission, and commitment to society.
In the future, Keyuan Pharmaceutical will steadfastly uphold its long-term vision, product-centric approach, altruistic mindset, and internationalization strategy. We will leverage budget management as a key driver, remain profit-oriented, use R&D as our core engine, and rely on a robust system for support. By continuously focusing on integrated raw material and formulation solutions, as well as excipient and formulation integration, we will deepen our efforts to cut costs and boost efficiency. At the same time, we’ll accelerate the transition toward digital and intelligent manufacturing and expedite the introduction of new products—ensuring that all annual targets are smoothly achieved and injecting strong momentum into the company’s long-term growth.
The successful convening of this special meeting on new product launches and existing product improvements marks a solid step forward for Keyuan Pharmaceutical in enhancing its core competitiveness and better meeting market demands. Moving forward, Keyuan Pharmaceutical will continue to uphold its development philosophy of innovation, pragmatism, and efficiency, relentlessly driving the company toward higher-quality, more profitable growth—and ultimately creating greater value for shareholders and society.
Latest News
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline